Zdrowie i gospodarka · 19/07/2024

FDA Drafts Guidance for Pediatric Inflammatory Bowel Disease Treatment Drugs

The US Food and Drug Administration (FDA) has released a draft guidance to help pharmaceutical companies develop effective treatments for pediatric inflammatory bowel disease, including ulcerative colitis and Crohn's disease, by outlining necessary attributes for clinical studies.